THORACIC NEOPLASMS

Clinical trials for THORACIC NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new THORACIC NEOPLASMS trials appear

Sign up with your email to follow new studies for THORACIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 3 Completed 2 Terminated 1

Targeted drug trial aims to outperform chemo for tough lung cancer

Disease control Terminated

This study compared a new targeted drug called pralsetinib against standard chemotherapy for people with advanced lung cancer that has spread and carries a specific genetic change called a RET fusion. The trial involved 223 participants worldwide who had not yet received treatmen…

Matched conditions: THORACIC NEOPLASMS

Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

THORACIC NEOPLASMS

Get alerted when new THORACIC NEOPLASMS trials appear

Targeted drug trial aims to outperform chemo for tough lung cancer